Coherus Biosciences Has Announced The Termination Of Its Tigit Program Collaboration With Shanghai Junshi Biosciences, With Plans To Wind Down Their Work In The Coming Months
Portfolio Pulse from Charles Gross
Coherus Biosciences has decided to end its Tigit program collaboration with Shanghai Junshi Biosciences. The companies will be winding down their joint efforts over the next few months, as reported in an 8-K filing.
January 10, 2024 | 11:09 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Coherus Biosciences has terminated its collaboration with Shanghai Junshi Biosciences on the Tigit program, which will be phased out in the near future.
The termination of the Tigit program collaboration is likely to be viewed negatively by investors as it may signal challenges or setbacks in the development pipeline for Coherus Biosciences. This could potentially lead to a short-term decline in the company's stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100